We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Novel PKCθ from Benchtop to Clinic.
- Authors
Hage-Sleiman, Rouba; Hamze, Asmaa B.; Reslan, Lina; Kobeissy, Hadile; Dbaibo, Ghassan
- Abstract
The protein kinases C (PKCs) are a family of serine/threonine kinases involved in regulating multiple essential cellular processes such as survival, proliferation, and differentiation. Of particular interest is the novel, calcium-independent PKCθ which plays a central role in immune responses. PKCθ shares structural similarities with other PKC family members, mainly consisting of an N-terminal regulatory domain and a C-terminal catalytic domain tethered by a hinge region. This isozyme, however, is unique in that it translocates to the immunological synapse between a T cell and an antigen-presenting cell (APC) upon T cell receptor-peptide MHC recognition. Thereafter, PKCθ interacts physically and functionally with downstream effectors to mediate T cell activation and differentiation, subsequently leading to inflammation. PKCθ-specific perturbations have been identified in several diseases, most notably autoimmune disorders, and hence the modulation of its activity presents an attractive therapeutic intervention. To that end, many inhibitors of PKCs and PKCθ have been developed and tested in preclinical and clinical studies. And although selectivity remains a challenge, results are promising for the future development of effective PKCθ inhibitors that would greatly advance the treatment of several T-cell mediated diseases.
- Subjects
PROTEIN kinases; IMMUNOLOGY; T cells; THERAPEUTICS; CLINICAL medicine; PHOSPHOTRANSFERASES
- Publication
Journal of Immunology Research, 2015, Vol 2015, p1
- ISSN
2314-8861
- Publication type
Article
- DOI
10.1155/2015/348798